Monday, August 10, 2026

Omega-3 Market Size, Share, Trends, and Growth Forecast - 2031

 The global Omega-3 Market is projected to reach USD 8.73 billion by 2031, registering a CAGR of 12.3% during the forecast period. The growth of the omega-3 market is driven by increasing consumer awareness regarding the health benefits of omega-3 fatty acids, particularly their role in cardiovascular, cognitive, and eye health. The growing demand for nutritional supplements, functional foods and beverages, infant nutrition, and pharmaceutical products is further contributing to market expansion.

Omega-3 fatty acids, particularly eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA), are essential fatty acids that the human body cannot efficiently synthesize. This has increased dependence on dietary sources and externally supplemented omega-3 ingredients. Manufacturers are increasingly incorporating omega-3 oils into capsules, powders, beverages, fortified foods, and other functional products while focusing on stability, bioavailability, and efficacy.

Fish oil, krill oil, and algal oil are among the most widely used sources of omega-3 fatty acids. Growing consumer preference for clean-label, sustainable, and naturally sourced ingredients is encouraging manufacturers to diversify their omega-3 portfolios. Increasing investments in algae-based omega-3 production and advancements in encapsulation technologies are also expected to create growth opportunities in the market.

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=227

DHA Segment to Register the Fastest Growth During the Forecast Period

Based on type, the DHA segment is expected to register the fastest growth during the forecast period. DHA is a long-chain polyunsaturated omega-3 fatty acid that plays an important structural role in the brain and retina. Its significance in neurological and visual development has resulted in increasing demand for DHA across infant nutrition, dietary supplements, functional foods, and beverages.

DHA is naturally present in marine sources such as salmon and tuna, as well as in fish oils, dairy products, and specialty eggs. The growing body of research highlighting the importance of DHA for brain, eye, and cardiovascular health is increasing consumer awareness and supporting its incorporation into nutritional products.

The increasing use of DHA in infant formulas is another major factor contributing to the growth of this segment. DHA is particularly important during early life stages because of its role in brain and visual development. Rising demand for premium infant nutrition products, coupled with increasing consumer awareness about the importance of essential fatty acids, is expected to support the growth of the DHA segment.

Furthermore, the increasing availability of algal-derived DHA is expanding options for vegetarian and vegan consumers. This trend is particularly significant in developed markets, where demand for sustainable and plant-based nutritional ingredients is increasing.

Infant Formula Segment to Register the Highest CAGR During the Forecast Period

Based on application, the infant formula segment is expected to register the highest CAGR during the forecast period. The growth of this segment can be attributed primarily to increasing recognition of DHA as an important nutrient fr infant brain and eye development.

The increasing adoption of fortified infant formulas containing DHA and EPA is being supported by growing awareness among parents and healthcare professionals regarding early-life nutrition. Manufacturers are also developing premium infant formulas designed to replicate the nutritional composition of human breast milk, further supporting the use of omega-3 ingredients.

Regulatory developments in Europe have also contributed to the incorporation of DHA into infant and follow-on formulas. The European regulatory framework specifies DHA requirements for infant and follow-on formulas, creating consistent demand for DHA ingredients from manufacturers operating in the region.

In addition, rising demand for organic, clean-label, and nutritionally enhanced infant formulas is creating opportunities for omega-3 suppliers. Emerging economies are also expected to contribute to market growth as birth rates, household purchasing power, awareness of infant nutrition, and access to premium nutritional products increase.

Request Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=227

Europe to Account for a Significant Share of the Omega-3 Market

Europe is expected to account for a significant share of the global Omega-3 Market during the forecast period. The regional market is supported by high consumer awareness, stringent regulatory standards, growing demand for preventive healthcare, and strong adoption of dietary supplements and functional foods.

European consumers are increasingly seeking premium nutritional products containing recognizable and sustainably sourced ingredients. This trend is driving demand for fish oil as well as alternative sources such as algal-derived omega-3. The increasing vegetarian and flexitarian populations in countries such as Germany, the UK, and France are further supporting demand for algae-based omega-3 products.

The presence of established omega-3 manufacturers and ongoing investments in research and development are strengthening the European market. Companies are focusing on developing innovative formulations and expanding production capacities to meet the increasing demand for omega-3 ingredients across dietary supplements, functional foods and beverages, infant nutrition, and pharmaceutical applications.

Leading Omega-3 Companies:

The report profiles key players such as BASF SE (Germany), Cargill, Incorporated (US), DSM-Firmenich (Netherlands), ADM (US), Kerry Group plc (Ireland), Aker BioMarine (Norway), Croda International plc (UK), Corbion (Netherlands), Pelagia AS (Norway), KD Pharma Group SA (Switzerland), GC Rieber (Norway), Cooke Aquaculture Inc. (Canada), GOLDEN OMEGA (Chile), Polaris (France), Btsa (Spain), KinOmega Biopharm Inc. (China), Rimfrost AS (Norway), Mara Renewables (Canada), Cellana Inc. (US), and AlgaeCytes Limited (UK).

No comments:

Post a Comment